The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥206.37Fair value¥2,779.95Bull¥4,392.93
FairClose
52-week traded range
52W low ¥2,628.0052W high ¥3,040.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
MEDIKIT CO.,LTD. closed at ¥2,877.00, 3.5% above the consensus fair value of ¥2,779.95 drawn from 9 valuation models.
Financial DNA score 69/100 — Strong. P/E of 13.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥1,111.42
-61.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=1%, r=10%, tg=3%, n=10yr
Graham Number
¥3,874.27
+34.7%
√(22.5 × EPS × BVPS)
EPS=206.37, BVPS=3232.58
P/E Fair Value
¥4,127.40
+43.5%
EPS × 20x (sector P/E)
EPS=206.37, Sector P/E=20x
Peter Lynch (PEG)
¥206.37
-92.8%
EPS × Growth% (PEG = 1 is fair)
EPS=206.37, g=1%
EV/EBITDA
¥4,392.93
+52.7%
(EBITDA × 10.5x − Net Debt) ÷ Shares
EBITDA=6.09B
Dividend Discount (DDM)
¥1,276.52
-55.6%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=100.12, r=10%, g=2%
Book Value (P/B)
¥1,616.29
-43.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3232.58, ROE=6.5%, g=3%, r=10%
Reverse DCF
¥2,877.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 2.3% | Historical: 1%
Margin of Safety
¥2,278.27
-20.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3037.7, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.